Partnerships
It’s the partnerships that make the difference. At Ultromics, we are committed to building working relationships throughout the health, pharmaceutical, and government sectors as we fight against heart failure.

Why Ultromics is Working with Leaders to Revolutionize the Fight Against Heart Failure
Overcoming the heart failure epidemic is a complex challenge that requires a collective effort.
Our experience partnering with healthcare professionals, patients, regulators, and technology companies has already led to game-changing solutions, but this is just the beginning.
The more we collaborate, the more we learn from one another. It’s time to combine our knowledge and resources to make a meaningful impact in the fight against heart failure.
Our Partnership Goals are to:
- Help achieve faster and more precise heart failure diagnoses that will improve patient outcomes
- Widen our existing knowledge base and increase our expertise on heart failure
- Continue to speed up AI innovation and scale up our platform
- Maintain our close connections within the global scientific community
- Increase inter-industry and academic-industry collaborations.
Our Partnership Goals are to:
- Help achieve faster and more precise heart failure diagnoses that will improve patient outcomes
- Widen our existing knowledge base and increase our expertise on heart failure
- Continue to speed up AI innovation and scale up our platforms
- Maintain our close connections within the global scientific community
- Increase inter-industry and academic-industry collaborations
Types of Partnerships
Health Systems & Private Practices
We have strong partnerships with health organizations, institutions, private practices, and resource centers that deliver healthcare services to their local communities, especially those focusing on finding more precise methods for identifying patients with heart failure.
Some of our current partners include Mayo Clinic, Northwestern, Oregon Health and Science University (OHSU), the University of Textas Southwestern, and the University of Chicago.
Government & Associations
Our experience with global associations and key government bodies with stakes in the medical industry has shown us how powerful these partnerships are. Combining our technology with the vast knowledge available through medical associations and public sector organizations can significantly improve the delivery of rapid and precise heart failure diagnoses to patients on a global scale.
We are currently partnering with the Foundation for the National Instututes of Health (FNIH) as part of the The Accelerating Medicines Partnership® Heart Failure (AMP® HF). We’re also a proud industry round table partner of the American Society of Echocardiography (ASE).
Pharmaceutical
The pharmaceutical sector plays a crucial role in novel approaches that enable early detection of heart failure. We’re thrilled to partner with innovative companies that are on the cutting edge of heart failure treatment, especially heart failure with preserved ejection fraction (HFpEF).
We are especially proud of our partnership with Janssen Pharmaceuticals, who is as committed to making a difference in the lives of heart failure patients as we are.
What we have achieved with our Partnerships
Published research and validation
Through our partnerships with Mayo Clinic, Janssen, and the NHS, we have trained and tested our technology to ensure trust for providers. This technology has gone on to be peer-reviewed in JACC and JASE.

Reliability in the heart failure sector
With our partners’ continuous support, our technology has proven its reliability through commercial clearances, including three FDA clearances, two CE marks, and two FDA breakthrough designations.

Access to world-leading science and data
Through our partnerships with Mayo Clinic, Janssen, and the NHS, we have trained and tested our technology to ensure trust for providers. This technology has gone on to be peer-reviewed in JACC and JASE.

Building a community of medical and tech experts
Through our partnerships with Mayo Clinic, Janssen, and the NHS, we have trained and tested our technology to ensure trust for providers. This technology has gone on to be peer-reviewed in JACC and JASE.

Partnerships and Customers






![]()
“We are pleased to welcome Ultromics to the Microsoft Azure Marketplace. Healthcare providers are looking for solutions that are trusted, secure and simple to deploy that come fully managed with 24/7 support. EchoGo is a secure solution enabling hospitals to take their workforce analysis off-site, via the Microsoft Azure cloud.”
What We Have Achieved with our Partnerships
Published Research and Validation
Reliability in the heart failure sector
Access to world-leading science and data
We are committed to ongoing partnerships with leading organizations as we seek to achieve continuous improvement of our unparalleled AI technology.
Building a community of medical and tech experts
What others say about our partnerships:
After Ultromics joined as a full partner The Accelerating Medicines Partnership® Heart Failure (AMP® HF), which includes the National Heart Lung and Blood Institute (NHLBI):
![]()
“The AMP Heart Failure program—and the high caliber of the partnership at its core—will help us better understand and treat [heart failure] with the goal of ultimately benefiting millions”
A powerful history of collaboration
Investors
Our investors have served as the backbone of our advances in AI for heart failure detection. They have enabled us to create and implement a groundbreaking, FDA-approved AI platform built on over ten years of known outcomes.
Listed below are just a few of our investors so far:

Connecting our Technology
We partner with tech leaders to offer seamless and secure ways to connect our technology. This is why Ultromics was thrilled to work with Microsoft to implement its AI service on the Microsoft Azure Marketplace. This online store provides certified software applications and services for use on Microsoft Azure, and the availability of EchoGo in the Microsoft Azure Marketplace created a streamlined way for hospitals to connect EchoGo with industry-leading capabilities


Latest News from Partnerships
View allLooking for partnerships?
We'd like to hear from you and about your interest in improving the diagnosis and treatment of heart failure.